Literature DB >> 17381426

Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes.

Matthew Spite1, Shahid P Baba, Yonis Ahmed, Oleg A Barski, Kanchan Nijhawan, J Mark Petrash, Aruni Bhatnagar, Sanjay Srivastava.   

Abstract

Phospholipid oxidation generates several bioactive aldehydes that remain esterified to the glycerol backbone ('core' aldehydes). These aldehydes induce endothelial cells to produce monocyte chemotactic factors and enhance monocyte-endothelium adhesion. They also serve as ligands of scavenger receptors for the uptake of oxidized lipoproteins or apoptotic cells. The biochemical pathways involved in phospholipid aldehyde metabolism, however, remain largely unknown. In the present study, we have examined the efficacy of the three mammalian AKR (aldo-keto reductase) families in catalysing the reduction of phospholipid aldehydes. The model phospholipid aldehyde POVPC [1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphocholine] was efficiently reduced by members of the AKR1, but not by the AKR6 or the ARK7 family. In the AKR1 family, POVPC reductase activity was limited to AKR1A and B. No significant activity was observed with AKR1C enzymes. Among the active proteins, human AR (aldose reductase) (AKR1B1) showed the highest catalytic activity. The catalytic efficiency of human small intestinal AR (AKR1B10) was comparable with the murine AKR1B proteins 1B3 and 1B8. Among the murine proteins AKR1A4 and AKR1B7 showed appreciably lower catalytic activity as compared with 1B3 and 1B8. The human AKRs, 1B1 and 1B10, and the murine proteins, 1B3 and 1B8, also reduced C-7 and C-9 sn-2 aldehydes as well as POVPE [1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphoethanolamine]. AKR1A4, B1, B7 and B8 catalysed the reduction of aldehydes generated in oxidized C(16:0-20:4) phosphatidylcholine with acyl, plasmenyl or alkyl linkage at the sn-1 position or C(16:0-20:4) phosphatidylglycerol or phosphatidic acid. AKR1B1 displayed the highest activity with phosphatidic acids; AKR1A4 was more efficient with long-chain aldehydes such as 5-hydroxy-8-oxo-6-octenoyl derivatives, whereas AKR1B8 preferred phosphatidylglycerol. These results suggest that proteins of the AKR1A and B families are efficient phospholipid aldehyde reductases, with non-overlapping substrate specificity, and may be involved in tissue-specific metabolism of endogenous or dietary phospholipid aldehydes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17381426      PMCID: PMC1925154          DOI: 10.1042/BJ20061743

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  56 in total

Review 1.  Atherosclerosis. the road ahead.

Authors:  C K Glass; J L Witztum
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

2.  Binding of pyridine nucleotide coenzymes to the beta-subunit of the voltage-sensitive K+ channel.

Authors:  S Q Liu; H Jin; A Zacarias; S Srivastava; A Bhatnagar
Journal:  J Biol Chem       Date:  2001-01-17       Impact factor: 5.157

3.  Physiological functions and hormonal regulation of mouse vas deferens protein (AKR1B7) in steroidogenic tissues.

Authors:  A Martinez; C Aigueperse; P Val; M Dussault; C Tournaire; M Berger; G Veyssière; C Jean; A Lefrançois Martinez
Journal:  Chem Biol Interact       Date:  2001-01-30       Impact factor: 5.192

4.  Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo.

Authors:  A D Watson; N Leitinger; M Navab; K F Faull; S Hörkkö; J L Witztum; W Palinski; D Schwenke; R G Salomon; W Sha; G Subbanagounder; A M Fogelman; J A Berliner
Journal:  J Biol Chem       Date:  1997-05-23       Impact factor: 5.157

5.  Phospholipid hydroxyalkenals, a subset of recently discovered endogenous CD36 ligands, spontaneously generate novel furan-containing phospholipids lacking CD36 binding activity in vivo.

Authors:  Shengqiang Gao; Renliang Zhang; Michael E Greenberg; Mingjiang Sun; Xi Chen; Bruce S Levison; Robert G Salomon; Stanley L Hazen
Journal:  J Biol Chem       Date:  2006-08-14       Impact factor: 5.157

6.  The reactive oxygen species--and Michael acceptor-inducible human aldo-keto reductase AKR1C1 reduces the alpha,beta-unsaturated aldehyde 4-hydroxy-2-nonenal to 1,4-dihydroxy-2-nonene.

Authors:  M E Burczynski; G R Sridhar; N T Palackal; T M Penning
Journal:  J Biol Chem       Date:  2000-11-01       Impact factor: 5.157

Review 7.  Platelet-activating factor and related lipid mediators.

Authors:  S M Prescott; G A Zimmerman; D M Stafforini; T M McIntyre
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

8.  Selective recognition of glutathiolated aldehydes by aldose reductase.

Authors:  K V Ramana; B L Dixit; S Srivastava; G K Balendiran; S K Srivastava; A Bhatnagar
Journal:  Biochemistry       Date:  2000-10-10       Impact factor: 3.162

9.  Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-2 position.

Authors:  G Subbanagounder; N Leitinger; D C Schwenke; J W Wong; H Lee; C Rizza; A D Watson; K F Faull; A M Fogelman; J A Berliner
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-10       Impact factor: 8.311

10.  The crystal structure of rat liver AKR7A1. A dimeric member of the aldo-keto reductase superfamily.

Authors:  Evelin Kozma; Elaine Brown; Elizabeth M Ellis; Adrian J Lapthorn
Journal:  J Biol Chem       Date:  2002-02-11       Impact factor: 5.157

View more
  44 in total

1.  Postischemic deactivation of cardiac aldose reductase: role of glutathione S-transferase P and glutaredoxin in regeneration of reduced thiols from sulfenic acids.

Authors:  Karin Wetzelberger; Shahid P Baba; Mahesh Thirunavukkarasu; Ye-Shih Ho; Nilanjana Maulik; Oleg A Barski; Daniel J Conklin; Aruni Bhatnagar
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

2.  Reductive metabolism increases the proinflammatory activity of aldehyde phospholipids.

Authors:  Elena Vladykovskaya; Evgeny Ozhegov; J David Hoetker; Zhengzhi Xie; Yonis Ahmed; Jill Suttles; Sanjay Srivastava; Aruni Bhatnagar; Oleg A Barski
Journal:  J Lipid Res       Date:  2011-09-27       Impact factor: 5.922

Review 3.  The aldo-keto reductase superfamily and its role in drug metabolism and detoxification.

Authors:  Oleg A Barski; Srinivas M Tipparaju; Aruni Bhatnagar
Journal:  Drug Metab Rev       Date:  2008       Impact factor: 4.518

4.  Aldo-keto reductase family 1 B10 protein detoxifies dietary and lipid-derived alpha, beta-unsaturated carbonyls at physiological levels.

Authors:  Linlin Zhong; Ziwen Liu; Ruilan Yan; Stephen Johnson; Yupei Zhao; Xiubin Fang; Deliang Cao
Journal:  Biochem Biophys Res Commun       Date:  2009-06-27       Impact factor: 3.575

5.  Dietary oxidized fat activates the oxidative stress-responsive transcription factors NF-κB and Nrf2 in intestinal mucosa of mice.

Authors:  Juliane Varady; Klaus Eder; Robert Ringseis
Journal:  Eur J Nutr       Date:  2011-03-10       Impact factor: 5.614

6.  AKR1B10 activates diacylglycerol (DAG) second messenger in breast cancer cells.

Authors:  Chenfei Huang; Zhe Cao; Jun Ma; Yi Shen; Yiwen Bu; Ramina Khoshaba; Guiyuan Shi; Dan Huang; Duan-Fang Liao; Haitao Ji; Junfei Jin; Deliang Cao
Journal:  Mol Carcinog       Date:  2018-06-28       Impact factor: 4.784

Review 7.  Hydroxyalkenals and oxidized phospholipids modulation of endothelial cytoskeleton, focal adhesion and adherens junction proteins in regulating endothelial barrier function.

Authors:  Peter V Usatyuk; Viswanathan Natarajan
Journal:  Microvasc Res       Date:  2011-05-06       Impact factor: 3.514

8.  Catalytic mechanism and substrate specificity of the beta-subunit of the voltage-gated potassium channel.

Authors:  Srinivas M Tipparaju; Oleg A Barski; Sanjay Srivastava; Aruni Bhatnagar
Journal:  Biochemistry       Date:  2008-08-02       Impact factor: 3.162

9.  TLRR (lrrc67) interacts with PP1 and is associated with a cytoskeletal complex in the testis.

Authors:  Rong Wang; Aseem Kaul; Ann O Sperry
Journal:  Biol Cell       Date:  2010-01-13       Impact factor: 4.458

10.  Reductive metabolism of AGE precursors: a metabolic route for preventing AGE accumulation in cardiovascular tissue.

Authors:  Shahid P Baba; Oleg A Barski; Yonis Ahmed; Timothy E O'Toole; Daniel J Conklin; Aruni Bhatnagar; Sanjay Srivastava
Journal:  Diabetes       Date:  2009-08-03       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.